<DOC>
	<DOC>NCT00398541</DOC>
	<brief_summary>Evaluate the antihypertensive and neuroprotective effects of Hyzaar(R) in elderly subjects in comparison with Natrilix(TM).</brief_summary>
	<brief_title>Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)</brief_title>
	<detailed_description />
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>ACEi or ARB naive or not taking ACEi or ARB concurrently for at least one month before the runin period Be able to carry out his or her own daily activity Be at least 50 years old at inclusion in the study Be diagnosed with mild to moderate hypertension, treated or untreated Literate Not taking any cognitiveenhanced agent at baseline Present with a memory complain ( spontaneous or informed by caregiver) Congestive heart failure with NYHA class &gt;2 Renal failure or renal insufficiency with serum creatinine &gt;1.4mg/dl chronic severe liver disease with abnormal GPT and GOT &gt;2 times of upper normal limits Diagnosed with major depression when entering the study Foreign language as his or her mother tongue so that the test results will not be reliable History of stroke or transient ischemic attack (stroke is defined as focal neurological sign progressing stepwise) Hypersensitive to the active ingredient and any other component of losartan potassium and indapamide tablets Major hearing loss/deafness and/or major visual impairment/blindness preventing from performing the tests Myocardial infarction within the past 6 months Single functioning kidney Anuria</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>